title: Drug Information Association (DIA) - 52nd Annual Meeting (June 26-30, 2016 - Philadelphia, Pennsylvania, USA).
abstract: The Drug Information Association's Annual Meeting is the largest global event which crosses all disciplines involved in the discovery development and life cycle management of healthcare products. The 2016 meeting, its 52nd occurrence, brought experts from regulatory and government agencies, industry, academia and health and patient organizations together to discuss novel therapies in development and how to use these to enhance health and well-being in patient groups, with the hope of increasing knowledge across all areas involved.
authors.affiliation: Thomson Reuters, Rockville, Maryland USA. regina.ballinger@thomsonreuters.com.
authors.forename: R
authors.initials: R
authors.lastname: Ballinger
authors.affiliation: Thomson Reuters, Rockville, Maryland USA.
authors.forename: M
authors.initials: M
authors.lastname: Spence
authors.affiliation: Thomson Reuters, Rockville, Maryland USA.
authors.forename: W
authors.initials: W
authors.lastname: Chalkley
mesh_terms: D055808:Drug Discovery; D006801:Humans; D035583:Rare Diseases / Q000188:drug therapy
keywords: CVD 103-HgR; Coartemether; Fluad; Gardasil 9; Hiberix; Optaflu; Priority Review Vouchers; Rare diseases